文献速递关节外科创伤骨科

慢性阻塞性肺疾病增加全髋关节置换术后内科与假体相关并发症风险

Increased Medical and Implant-Related Complications in Total Hip Arthroplasty Patients With Underlying Chronic Obstructive Pulmonary Disease.
PubMed 文献 · J Arthroplasty · 2021-02-10

基于PearlDiver Mariners数据库的回顾性队列研究,纳入2010至2018年97,784例伴COPD及338,243例不伴COPD的原发性全髋关节置换患者。伴COPD患者30天再入院、肺炎、脱位、假体感染、假体周围骨折及1年翻修风险均显著升高。

要点

  • 伴COPD的THA患者30天再入院风险升高(aOR=1.17)。
  • 伴COPD的THA患者30天肺炎风险升高(aOR=2.07)。
  • 伴COPD的THA患者假体并发症及1年翻修风险均升高。

核心结论

  • 伴基础COPD的THA患者较不伴COPD者具有更高的合并症、呼吸系统并发症、假体并发症及翻修手术发生率。

研究设计与样本

  • 回顾性队列研究,使用PearlDiver Mariners数据库,将原发性THA(CPT-27130)患者分为伴COPD(含哮喘)组与不伴COPD组。
  • 共纳入2010至2018年97,784例伴COPD的THA患者和338,243例不伴COPD的THA患者。
  • 采用逻辑回归计算30天再入院、COPD急性加重、肺炎、其他呼吸系统并发症及脱位、机械性松动、假体周围感染的发生率,采用Cox比例风险回归评估翻修风险,所有回归均控制年龄、性别及与COPD相关的合并症。
  • 证据等级为III级。

主要发现

  • 伴COPD的THA患者30天再入院风险更高(aOR=1.17,95%CI 1.11-1.23,P<.0001)。
  • 伴COPD的THA患者30天肺炎风险更高(aOR=2.07,95%CI 1.76-2.44,P<.0001)。
  • 伴COPD的THA患者30天脱位风险更高(aOR=1.31,95%CI 1.19-1.45,P<.0001)。
  • 伴COPD的THA患者30天假体周围感染风险更高(aOR=1.25,95%CI 1.14-1.37,P<.0001)。
  • 伴COPD的THA患者30天假体周围骨折风险更高(aOR=1.19,95%CI 1.07-1.32,P=.0015)。

关键数值与推荐

  • 伴COPD的THA患者1年翻修率为3.3%,翻修风险高于不伴COPD者(aOR=1.11,95%CI 1.06-1.16,P<.0001)。

临床怎么用

  • 对拟行THA的COPD患者,应充分评估并优化呼吸系统状况,告知其再入院、肺炎、假体并发症及翻修风险升高。
  • 围手术期应加强呼吸系统并发症监测与假体相关并发症的预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstructive pulmonary disease (COPD) has been associated with impaired bone metabolism. The purpose of this study is to investigate rates of readmission, respiratory complications, implant-related complications, and revision after total hip arthroplasty (THA) in patients with and without underlying COPD. METHODS: The PearlDiver Mariners database was used to divide patients undergoing primary THA (CPT-27130) into two cohorts: 1) THA with COPD (including asthma) or 2) THA without COPD. The incidence of 30-day readmission, COPD exacerbation, pneumonia, other respiratory complications as well as dislocations, mechanical loosening, and joint prosthetic infection was calculated through logistic regression. The risk of THA revision was also assessed through Cox-proportional hazards regression. All regression controlled for age, gender, and medical comorbidities found to be associated with COPD. RESULTS: Between 2010 and 2018, 97,784 THA patients with COPD and 338,243 THA patient without COPD were studied. THA patients with COPD had higher risk of 30-day readmission (aOR = 1.17, 95% CI 1.11-1.23, P < .0001). There was higher risk of 30-day pneumonia (aOR = 2.07, 95% CI 1.76-2.44, P < .0001). THA patients with COPD also faced higher risk of 30-day dislocations (aOR = 1.31, 95% CI 1.19-1.45, P < .0001), joint prosthetic infections (aOR = 1.25, 95% CI 1.14-1.37, P < .0001), and periprosthetic fracture (aOR = 1.19, 95% CI 1.07-1.32, P = .0015). Regarding revisions, 3.3% of THA patients with COPD underwent THA revision at 1 year, a higher risk than THA patients without COPD (aOR = 1.11, 95% CI 1.06-1.16, P < .0001). CONCLUSION: Patients undergoing THA with underlying COPD face a higher rate of comorbidities, respiratory complications, implant complications, and revision surgeries, than patients without COPD. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Yang DS, Glasser J, Lemme NJ, et al. Increased Medical and Implant-Related Complications in Total Hip Arthroplasty Patients With Underlying Chronic Obstructive Pulmonary Disease. J Arthroplasty. 2021. PMID: 33674163. doi:10.1016/j.arth.2021.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。